Abbott Laboratories Corporation

Mira Hinman

Rolf Wagner

Teresa A Rosenberg

Curt S Cooper

Douglas M Kalvin

David D Anderson

Bruce A Beutel

Yu-Gui Gu

Daniel P Larson

Todd D Bosse

Zhenkun Ma

Dachun Liu

Todd Warren Rockway

John T Randolph

David A Betebenner

Douglas K Hutchinson

Allan C Krueger

Larry L Klein

Kent D Stewart

Ming Clinton Yeung

Charles A Flentge

Keith F McDaniel

Hong Yong

Michael D Tufano

Thomas B Borchardt

Xenia Beebe Searle

Christopher E Motter

M Robert Leanna

Russell Drew Cink

Darold L Madigan

Brian E Green

Vincent S Stoll

Peggy Huang

William Sanders

Robert F Keyes

Moshe Weitzberg

Richard D Bishop

Bradley D Gates

Linda M Lynch

John R Bellettini

Peter Dandliker

Caroline David

Todd M Hansen

Richard F Clark

Tianyuan Zhang

Fabio Palazzo

Tamara Rehm

Antibacterials having formula (I) and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates used in the processes, compositions containing the compounds, and methods of prophylaxis and treatment of bacterial infections using the compounds are disclosed.

Antibacterial compounds

Bacterial protein synthesis-inhibiting compounds having formula (I)  and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates in the processes, compositions containing the compounds, and methods of using the compounds are disclosed.

Bacterial protein synthesis-inhibiting compounds having formula (I) and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates in the processes, compositions containing the compounds, and methods of using the compounds are disclosed.

Naphthyridine-based antibacterial compositions

Compounds having the formula are hepatitis C(HCV) polymerase inhibitors. Also disclosed are a composition and method for inhibiting hepatitis C(HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes.

Anti-infective agents

Compounds having the formula are hepatitis C (HCV) polymerase inhibitors. Also disclosed are a composition and method for inhibiting hepatitis C (HCV) polymerase, processes for making the compounds, and synthetic intermediates employed in the processes.

Bacterial protein synthesis-inhibiting compounds having formula (I) and salts, prodrugs, salts of prodrugs, and metabolites thereof, processes for making the compounds and intermediates in the processes, compositions containing the compounds, and methods of using the compounds are disclosed.

Growing community of inventors

Libertyville, IL, United States of America

Mira Hinman